推荐阅读

［1］FEARON E R，VOGELSTEIN B.A genetic model for colorectal tumorigenesis［J］. Cell，1990，61（5）：759-767.

［2］MAUGHAN T S，ADAMS R A，SMITH C G，et al. Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer：results of the randomised phase 3 MRC COIN trial［J］.Lancet，2011，377（9783）：2103-2114.

［3］SOUGLAKOS J，PHILIPS J，WANG R，et al. Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer［J］.Br J Cancer，2009，101（3）：465-472.

［4］RICHMAN S D，SEYMOUR M T，CHAMBERS P，et al.KRAS and BRAF mutations in advanced colorectal cancer are associated with poor prognosis but do not preclude benefit from oxaliplatin or irinotecan：results from the MRC FOCUS trial［J］. J Clin Oncol，2009，27（35）：5931-5937.

［5］REICHMANN A，MARTIN P，LEVIN B. Chromosomal banding patterns in human large bowel cancer［J］. Int J Cancer，1981，28（4）：431-440.

［6］PELKA K，HOFREE M，CHEN J H，et al. Spatially organized multicellular immune hubs in human colorectal cancer［J］.Cell，2021，184（18）：4734-4752.

［7］LE D T，URAM J N，WANG H，et al. PD-1 blockade in tumors with mismatch-repair deficiency［J］. N Engl J Med，2015，372（26）：2509-2520.

［8］WANG L，CUNNINGHAM J M，WINTERS J L，et al. BRAF mutations in colon cancer are not likely attributable to defective DNA mismatch repair［J］. Cancer Res，2003，63（17）：5209-5212.

［9］TAKAYAMA T，KATSUKI S，TAKAHASHI Y，et al. Aberrant crypt foci of the colon as precursors of adenoma and cancer［J］. N Engl J Med，1998，339（18）：1277-1284.

［10］KERR J F，WYLLIE A H，CURRIE A R. Apoptosis：a basic biological phenomenon with wide-ranging implications in tissue kinetics［J］. Br J Cancer，1972，26（4）：239-257.

［11］ZHANG Z，ZHANG Y，XIA S，et al. Gasdermin E suppresses tumour growth by activating anti-tumour immunity［J］.Nature，2020，579（7799）：415-420.

［12］ASFAHA S，HAYAKAWA Y，MULEY A，et al. Krt19（+）/Lgr5（-）cells are radioresistant cancer-initiating stem cells in the colon and intestine［J］. Cell Stem Cell，2015，16（6）：627-638.

［13］DE SOUSA E M F，DE SAUVAGE F J. Cellular plasticity in intestinal homeostasis and disease［J］. Cell Stem Cell，2019，24（1）：54-64.

［14］MORRAL C，STANISAVLJEVIC J，HERNANDOMOMBLONA X，et al. Zonation of ribosomal dna transcription defines a stem cell hierarchy in colorectal cancer［J］. Cell Stem Cell，2020，26（6）：845-861.

［15］ZHANG L，LI J，TIAN D，et al. Theranostic combinatorial drug-loaded coated cubosomes for enhanced targeting and efficacy against cancer cells［J］. Cell Death Dis，2020，11（1）：1.

［16］LI S，PENG Y，PANCHENKO A R. DNA methylation：Precise modulation of chromatin structure and dynamics［J］.Curr Opin Struct Biol，2022，75：102430.

［17］AUDIA J E，CAMPBELL R M. Histone modifications and cancer［J］. Cold Spring Harbor perspectives in biology，2016，8（4）：a019521.

［18］GARGALIONIS A N，PIPERI C，ADAMOPOULOS C，et al. Histone modifications as a pathogenic mechanism of colorectal tumorigenesis［J］. Int J Biochem Cell B，2012，44（8）：1276-1289.